Raju Prasad Crispr Therapeutics Ag (CRSP) insider trading activity

Raju Prasad is Chief Financial Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 6,767 shares of CRSP, which is worth approximately $374,350. The most recent transaction as insider was on Dec 22, 2025, when has been sold 10,000 shares (Common Shares) at a price of $56.11 per share, resulting in proceeds of $561,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.77K

59.64% 3M change

4.49% 12M change

Total Value Held $374,350

Raju Prasad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2025	SELL Open market or private sale	$561,100 $56.11 p/Share	10,000 Reduced 59.64%	6,767 Common Shares
Mar 21 2025	SELL Open market or private sale	$90,582 $41.23 p/Share	2,197 Reduced 11.59%	16,767 Common Shares
Mar 20 2025	BUY Exercise of conversion of derivative security	-	6,250 Added 24.79%	18,964 Common Shares
Mar 17 2025	SELL Open market or private sale	$157,251 $41.8 p/Share	3,762 Reduced 22.83%	12,714 Common Shares
Mar 14 2025	BUY Exercise of conversion of derivative security	-	10,000 Added 37.77%	16,476 Common Shares
Mar 15 2024	SELL Open market or private sale	$256,159 $72.69 p/Share	3,524 Reduced 35.24%	6,476 Common Shares
Mar 14 2024	BUY Exercise of conversion of derivative security	-	10,000 Added 50.0%	10,000 Common Shares

Raju Prasad

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Value

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

Operation

Value

Type

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP

Account